OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study
J. Braun, Xenofon Baraliakos, Atul Deodhar, et al.
Annals of the Rheumatic Diseases (2016) Vol. 76, Iss. 6, pp. 1070-1077
Open Access | Times Cited: 241
J. Braun, Xenofon Baraliakos, Atul Deodhar, et al.
Annals of the Rheumatic Diseases (2016) Vol. 76, Iss. 6, pp. 1070-1077
Open Access | Times Cited: 241
Showing 1-25 of 241 citing articles:
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
Sofía Ramiro, Elena Nikiphorou, Alexandre Sepriano, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 1, pp. 19-34
Open Access | Times Cited: 519
Sofía Ramiro, Elena Nikiphorou, Alexandre Sepriano, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 1, pp. 19-34
Open Access | Times Cited: 519
Ankylosing spondylitis: etiology, pathogenesis, and treatments
Wei Zhu, Xuxia He, Kai-Yuan Cheng, et al.
Bone Research (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 371
Wei Zhu, Xuxia He, Kai-Yuan Cheng, et al.
Bone Research (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 371
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies
José María García Ruiz de Morales, L. Puig, E. Daudén, et al.
Autoimmunity Reviews (2019) Vol. 19, Iss. 1, pp. 102429-102429
Open Access | Times Cited: 271
José María García Ruiz de Morales, L. Puig, E. Daudén, et al.
Autoimmunity Reviews (2019) Vol. 19, Iss. 1, pp. 102429-102429
Open Access | Times Cited: 271
Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study
Philip J. Mease, Désirée van der Heijde, Robert Landewé, et al.
Annals of the Rheumatic Diseases (2018), pp. annrheumdis-212687
Open Access | Times Cited: 249
Philip J. Mease, Désirée van der Heijde, Robert Landewé, et al.
Annals of the Rheumatic Diseases (2018), pp. annrheumdis-212687
Open Access | Times Cited: 249
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort
Christoph Molnar, Almut Scherer, Xenofon Baraliakos, et al.
Annals of the Rheumatic Diseases (2017) Vol. 77, Iss. 1, pp. 63-69
Open Access | Times Cited: 237
Christoph Molnar, Almut Scherer, Xenofon Baraliakos, et al.
Annals of the Rheumatic Diseases (2017) Vol. 77, Iss. 1, pp. 63-69
Open Access | Times Cited: 237
The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
Dennis McGonagle, Iain B. McInnes, Bruce Kirkham, et al.
Annals of the Rheumatic Diseases (2019) Vol. 78, Iss. 9, pp. 1167-1178
Open Access | Times Cited: 206
Dennis McGonagle, Iain B. McInnes, Bruce Kirkham, et al.
Annals of the Rheumatic Diseases (2019) Vol. 78, Iss. 9, pp. 1167-1178
Open Access | Times Cited: 206
Effects of the IL-23–IL-17 pathway on bone in spondyloarthritis
Ellen M. Gravallese, Georg Schett
Nature Reviews Rheumatology (2018) Vol. 14, Iss. 11, pp. 631-640
Closed Access | Times Cited: 182
Ellen M. Gravallese, Georg Schett
Nature Reviews Rheumatology (2018) Vol. 14, Iss. 11, pp. 631-640
Closed Access | Times Cited: 182
Paradoxical gastrointestinal effects of interleukin-17 blockers
Marine Fauny, David Moulin, Ferdinando D’Amico, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 9, pp. 1132-1138
Open Access | Times Cited: 178
Marine Fauny, David Moulin, Ferdinando D’Amico, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 9, pp. 1132-1138
Open Access | Times Cited: 178
IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis
Sungsin Jo, Sung Eun Wang, Young Lim Lee, et al.
Arthritis Research & Therapy (2018) Vol. 20, Iss. 1
Open Access | Times Cited: 143
Sungsin Jo, Sung Eun Wang, Young Lim Lee, et al.
Arthritis Research & Therapy (2018) Vol. 20, Iss. 1
Open Access | Times Cited: 143
IL-17 in Rheumatoid Arthritis and Precision Medicine: From Synovitis Expression to Circulating Bioactive Levels
Marie Robert, Pierre Miossec
Frontiers in Medicine (2019) Vol. 5
Open Access | Times Cited: 141
Marie Robert, Pierre Miossec
Frontiers in Medicine (2019) Vol. 5
Open Access | Times Cited: 141
Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response
L. Sawyer, K Malottki, Celia Sabry-Grant, et al.
PLoS ONE (2019) Vol. 14, Iss. 8, pp. e0220868-e0220868
Open Access | Times Cited: 137
L. Sawyer, K Malottki, Celia Sabry-Grant, et al.
PLoS ONE (2019) Vol. 14, Iss. 8, pp. e0220868-e0220868
Open Access | Times Cited: 137
Revisiting the gut–joint axis: links between gut inflammation and spondyloarthritis
Eric Gracey, Lars Vereecke, Dermot McGovern, et al.
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 8, pp. 415-433
Closed Access | Times Cited: 132
Eric Gracey, Lars Vereecke, Dermot McGovern, et al.
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 8, pp. 415-433
Closed Access | Times Cited: 132
Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study
J. Braun, Xenofon Baraliakos, Atul Deodhar, et al.
Lara D. Veeken (2018) Vol. 58, Iss. 5, pp. 859-868
Open Access | Times Cited: 131
J. Braun, Xenofon Baraliakos, Atul Deodhar, et al.
Lara D. Veeken (2018) Vol. 58, Iss. 5, pp. 859-868
Open Access | Times Cited: 131
Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis
Désirée van der Heijde, J. Braun, Atul Deodhar, et al.
Lara D. Veeken (2018) Vol. 58, Iss. 3, pp. 388-400
Open Access | Times Cited: 128
Désirée van der Heijde, J. Braun, Atul Deodhar, et al.
Lara D. Veeken (2018) Vol. 58, Iss. 3, pp. 388-400
Open Access | Times Cited: 128
Recent advances in ankylosing spondylitis: understanding the disease and management
Leticia Garcia‐Montoya, Hanna Gul, Paul Emery
F1000Research (2018) Vol. 7, pp. 1512-1512
Open Access | Times Cited: 126
Leticia Garcia‐Montoya, Hanna Gul, Paul Emery
F1000Research (2018) Vol. 7, pp. 1512-1512
Open Access | Times Cited: 126
Role of IL-17 in asthma pathogenesis and its implications for the clinic
Rakhee K. Ramakrishnan, Saba Al Heialy, Qutayba Hamid
Expert Review of Respiratory Medicine (2019) Vol. 13, Iss. 11, pp. 1057-1068
Closed Access | Times Cited: 126
Rakhee K. Ramakrishnan, Saba Al Heialy, Qutayba Hamid
Expert Review of Respiratory Medicine (2019) Vol. 13, Iss. 11, pp. 1057-1068
Closed Access | Times Cited: 126
Cytokines and costimulation in acute graft-versus-host disease
Geoffrey R. Hill, Motoko Koyama
Blood (2020) Vol. 136, Iss. 4, pp. 418-428
Open Access | Times Cited: 107
Geoffrey R. Hill, Motoko Koyama
Blood (2020) Vol. 136, Iss. 4, pp. 418-428
Open Access | Times Cited: 107
Axial spondyloarthritis: new advances in diagnosis and management
Christopher T. Ritchlin, Iannis E. Adamopoulos
BMJ (2021), pp. m4447-m4447
Closed Access | Times Cited: 102
Christopher T. Ritchlin, Iannis E. Adamopoulos
BMJ (2021), pp. m4447-m4447
Closed Access | Times Cited: 102
Secukinumab: A Review in Ankylosing Spondylitis
Hannah A. Blair
Drugs (2019) Vol. 79, Iss. 4, pp. 433-443
Open Access | Times Cited: 99
Hannah A. Blair
Drugs (2019) Vol. 79, Iss. 4, pp. 433-443
Open Access | Times Cited: 99
Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study
Alan Kivitz, Ulf Wagner, Eva Dokoupilová, et al.
Rheumatology and Therapy (2018) Vol. 5, Iss. 2, pp. 447-462
Open Access | Times Cited: 93
Alan Kivitz, Ulf Wagner, Eva Dokoupilová, et al.
Rheumatology and Therapy (2018) Vol. 5, Iss. 2, pp. 447-462
Open Access | Times Cited: 93
Biologics in SAPHO syndrome: A systematic review
Dimitrios Daoussis, Γεωργία Κωνσταντοπούλου, Pantelis Kraniotis, et al.
Seminars in Arthritis and Rheumatism (2018) Vol. 48, Iss. 4, pp. 618-625
Closed Access | Times Cited: 90
Dimitrios Daoussis, Γεωργία Κωνσταντοπούλου, Pantelis Kraniotis, et al.
Seminars in Arthritis and Rheumatism (2018) Vol. 48, Iss. 4, pp. 618-625
Closed Access | Times Cited: 90
Interleukin‐17A Inhibition Diminishes Inflammation and New Bone Formation in Experimental Spondyloarthritis
Melissa N. van Tok, Leonie M. van Duivenvoorde, Ina Krämer, et al.
Arthritis & Rheumatology (2018) Vol. 71, Iss. 4, pp. 612-625
Closed Access | Times Cited: 90
Melissa N. van Tok, Leonie M. van Duivenvoorde, Ina Krämer, et al.
Arthritis & Rheumatology (2018) Vol. 71, Iss. 4, pp. 612-625
Closed Access | Times Cited: 90
Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker
Iva Sorić Hosman, Ivanka Kos, Lovro Lamot
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 89
Iva Sorić Hosman, Ivanka Kos, Lovro Lamot
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 89
2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis
Daniel Wendling, C. Lukas, Clément Prati, et al.
Joint Bone Spine (2018) Vol. 85, Iss. 3, pp. 275-284
Closed Access | Times Cited: 87
Daniel Wendling, C. Lukas, Clément Prati, et al.
Joint Bone Spine (2018) Vol. 85, Iss. 3, pp. 275-284
Closed Access | Times Cited: 87
The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
Hiroyuki Tsukazaki, Takashi Kaito
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6401-6401
Open Access | Times Cited: 82
Hiroyuki Tsukazaki, Takashi Kaito
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6401-6401
Open Access | Times Cited: 82
